Market Indices
Sector Heatmap
IONS — Ionis Pharmaceuticals, Inc. Common Stock
NasdaqIonis Pharmaceuticals, Inc. Common Stock
- O
- 43.75
- H
- 43.96
- L
- 42.63
- V
- 2.58M
IONS — Latest News & Headlines
20 StoriesIonis Pharmaceuticals (NasdaqGS:IONS) Stock Forecast & Analyst Predictions - Simply Wall Street
Ionis Pharmaceuticals (NasdaqGS:IONS) Stock Forecast & Analyst Predictions Simply Wall Street
Ionis Pharmaceuticals Stock Price Forecast. Should You Buy IONS? - StockInvest.us
Ionis Pharmaceuticals Stock Price Forecast. Should You Buy IONS? StockInvest.us
NVS, IONS, AMGN Stocks Drop After-Hours — What’s Driving The Selloff? - Stocktwits
NVS, IONS, AMGN Stocks Drop After-Hours — What’s Driving The Selloff? Stocktwits
A kidney disease can progress to kidney failure in up to half of patients within 20 years. Ionis' drug met its trial goal. - Stock Titan
A kidney disease can progress to kidney failure in up to half of patients within 20 years. Ionis' drug met its trial goal. Stock Titan
IONS Oct 2026 60.000 call (IONS261016C00060000) Stock Price, News, Quote & History - Yahoo! Finance Canada
IONS Oct 2026 60.000 call (IONS261016C00060000) Stock Price, News, Quote & History Yahoo! Finance Canada
When Will Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Become Profitable? - Moomoo
When Will Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Become Profitable? Moomoo
Avoiding Lag: Real-Time Signals in (IONS) Movement - Stock Traders Daily
Avoiding Lag: Real-Time Signals in (IONS) Movement Stock Traders Daily
JPMorgan cuts Ionis Pharmaceuticals stock price target on launch concerns - Investing.com
JPMorgan cuts Ionis Pharmaceuticals stock price target on launch concerns Investing.com
What Ionis Pharmaceuticals (IONS)'s Phase 3 Wins Mean For Shareholders - Simply Wall Street
What Ionis Pharmaceuticals (IONS)'s Phase 3 Wins Mean For Shareholders Simply Wall Street
General Counsel earns 46,545 stock units at Ionic Digital (IOND), subject to employment-based vesting. - Stock Titan
General Counsel earns 46,545 stock units at Ionic Digital (IOND), subject to employment-based vesting. Stock Titan
Idorsia (SWX:IDIA) Stock Could Be Fully Priced On Current Sales - Yahoo Finance
Idorsia (SWX:IDIA) Stock Could Be Fully Priced On Current Sales Yahoo Finance
Ionis Pharmaceuticals (IONS) Reports Fresh Phase 3 Wins, Is The 49% Discount Justified? - Simply Wall Street
Ionis Pharmaceuticals (IONS) Reports Fresh Phase 3 Wins, Is The 49% Discount Justified? Simply Wall Street
A $2.5B award threshold is met, and Ionic Digital (IOND)'s development chief earns stock units. - Stock Titan
A $2.5B award threshold is met, and Ionic Digital (IOND)'s development chief earns stock units. Stock Titan
Ionis Pharmaceuticals (IONS) Posted Two Positive Phase 3 Trial Readouts - Simply Wall Street
Ionis Pharmaceuticals (IONS) Posted Two Positive Phase 3 Trial Readouts Simply Wall Street
IONS Oct 2026 42.500 call (IONS261016C00042500) stock price, news, quote and history - Yahoo Finance Singapore
IONS Oct 2026 42.500 call (IONS261016C00042500) stock price, news, quote and history Yahoo Finance Singapore
A $2.5B threshold unlocks performance stock units for Ionic Digital (IOND) CFO Chris Hickman. - Stock Titan
A $2.5B threshold unlocks performance stock units for Ionic Digital (IOND) CFO Chris Hickman. Stock Titan
Ionis Pharmaceuticals Fell 45% With The Case Still Split - Simply Wall Street
Ionis Pharmaceuticals Fell 45% With The Case Still Split Simply Wall Street
After a $2.5B threshold is met, Ionic Digital (IOND)'s strategy chief acquires stock units. - Stock Titan
After a $2.5B threshold is met, Ionic Digital (IOND)'s strategy chief acquires stock units. Stock Titan
After a $2.5B threshold is met, Ionic Digital (IOND)'s CEO earns a performance stock award. - Stock Titan
After a $2.5B threshold is met, Ionic Digital (IOND)'s CEO earns a performance stock award. Stock Titan
Canaccord reiterates Ionis stock rating on positive trial results - Investing.com
Canaccord reiterates Ionis stock rating on positive trial results Investing.com